119 Perspectives on cancer screening participation 38. QMethod Software. Online Studies and Analysis. 2021. https://qmethodsoftware.com. Accessed June 2021. 39. Bevolkingsonderzoek Zuid-West. Jaarverslag 2019. https://www. bevolkingsonderzoeknederland.nl/media/1442/jaarverslag-2019_def.pdf. Accessed June 2021. 40. Gemeente Den Haag. Den Haag in cijfers/bevolking 2021. https://denhaag.incijfers.nl/ dashboard/Overzichten/Bevolking/. Accessed March 2022. 41. Gemeente Amsterdam. 2021. https://data.amsterdam.nl/datasets/bx_HyaOipADV-Q/ stand-van-de-bevolking-amsterdam/?term=Stand+van+de+bevolking+Amsterdam. Accessed April 2022. 42. Gemeente Rotterdam. Onderzoek010/bevolking 2021. https://onderzoek010.nl/ dashboard/onderzoek010/Bevolking. Accessed April 2022. 43. Cooke R, French DP. How well do the theory of reasoned action and theory of planned behaviour predict intentions and attendance at screening programmes? A meta-analysis. Psychology and health. 2008;23(7):745-65. 44. Cullati S, Charvet-Bérard AI, Perneger TV. Cancer screening in a middle-aged general population: factors associated with practices and attitudes. BMC public health. 2009;9(1):1-11. 45. Douma LN, Uiters E, Timmermans DR. Why are the public so positive about colorectal cancer screening? BMC Public Health. 2018;18(1):1-9. 46. Savage SA, Clarke VA. Older women’s illness representations of cancer: a qualitative study. Health education research. 1998;13(4):529-44. 47. Douma LN, Uiters E, Timmermans DR. The Dutch public are positive about the colorectal cancer-screening programme, but is this a well-informed opinion? BMC public health. 2016;16(1):1-12. 48. Gigerenzer G. Breast cancer screening pamphlets mislead women. Bmj. 2014;348. 49. Gigerenzer G, Mata J, Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. Journal of the National Cancer Institute. 2009;101(17):1216-20. 50. Dubayova T, van Dijk JP, Nagyova I, Rosenberger J, Havlikova E, Gdovinova Z, et al. The impact of the intensity of fear on patient’s delay regarding health care seeking behavior: a systematic review. International journal of public health. 2010;55(5):459-68. 51. McCaul KD, Schroeder DM, Reid PA. Breast cancer worry and screening: some prospective data. Health psychology. 1996;15(6):430. 52. Vrinten C, Waller J, von Wagner C, Wardle J. Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiology and Prevention Biomarkers. 2015;24(2):400-5. 53. Vernon SW. Risk perception and risk communication for cancer screening behaviors: a review. JNCI Monographs. 1999;1999(25):101-19. 54. Atkinson TM, Salz T, Touza KK, Li Y, Hay JL. Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis. Journal of behavioral medicine. 2015;38(6):837-50. 55. Chan CW, Yang SB, Gu C, Wang X, Tao L. Perception of cervical cancer risk and screening behavior: a literature review. International journal of nursing knowledge. 2015;26(1):2-18. 56. Goodwin BC, Myers L, Ireland MJ, March S, Ralph N, Dunn J, et al. Barriers to home bowel cancer screening. Psycho‐Oncology. 2021;30(10):1756-64. 57. De Nooijer D, De Waart F, Van Leeuwen A, Spijker W. Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance. Nederlands tijdschrift voor geneeskunde. 2005;149(42):2339-43. 4
RkJQdWJsaXNoZXIy MTk4NDMw